Panagora Asset Management Inc Selecta Biosciences Inc Transaction History

Panagora Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $1.4 $7,560 - $15,798	-11,285 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.23 - $3.31 $13,880 - $37,353	11,285 New	11,285 $14,000
Q3 2021 Nov 10, 2021	SELL	$3.36 - $4.62 $4,845 - $6,662	-1,442 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$2.82 - $5.01 $3,034 - $5,390	-1,076 Reduced 42.73%	1,442 $6,000
Q4 2020 Feb 10, 2021	BUY	$1.64 - $3.42 $2,563 - $5,345	1,563 Added 163.66%	2,518 $8,000
Q3 2020 Nov 13, 2020	BUY	$2.18 - $2.84 $2,081 - $2,712	955 New	955 $2,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.